IHC staining of NR2F2 in breast cancer primary biopsy tissue with metastatic lymph nodes demonstrated that a reduction in COUP-TFII was associated with an increased tumour stage and worse progression of malignancy in breast cancer. This evidence concerns the gene NR2F2 and breast carcinoma.